Non-gelatin soft capsule system
AssigneeR.P. Scherer Technologies, LLC
InventorsKeith E. Tanner, Rickey S. Shelley, Norman S. Stroud, Elizabeth Youngblood
Life of this patent
Estimating the term…
Abstract
A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the active ingredients and excipients, are difficult or impossible to commercially encapsulate in gelatin capsules. In particular, the system is adapted for the encapsulation of highly basic, or alkaline, fills. The system provides for a predominantly starch and gelling carrageenan based shell, which displays high resistance to both concentrated fills and to alkaline fills, in particular, to those fills which contain the salt or salts of weak acids and strong bases.
Claims8
-28. (canceled)
A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:
- a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1;
- and
- a fill, said fill comprising:
- at least one active ingredient dissolved or dispersed in at least one carrier,
- wherein the fill has a pH greater than 7.5,
- wherein the shell exhibits resistance to degradation caused by alkaline fills,
- wherein said shell further comprises water, a plasticizer and a buffer, and
- wherein said gelling carrageenan comprises kappa-carrageenan.
A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:
- a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1;
- and
- a fill, said fill comprising:
- at least one active ingredient dissolved or dispersed in at least one carrier,
- wherein the fill has a pH greater than 7.5,
- wherein the shell exhibits resistance to degradation caused by alkaline fills,
- wherein said shell further comprises water, a plasticizer and a buffer, and
- wherein said gelling carrageenan comprises a mixture of iota-carrageenan and kappa-carrageenan.
A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:
- a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1;
- and
- a fill, said fill comprising:
- acetaminophen dissolved or dispersed in at least one carrier, and
- an acidic agent sufficient to partially neutralize a portion of said acetaminophen by forming an equilibrium between (1) said acetaminophen and (2) the salt of said acetaminophen and said acidic agent,
- wherein the fill has a pH greater than 7.5, and
- wherein the shell exhibits resistance to degradation caused by alkaline fills.
A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:
- a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1;
- and
- a fill, said fill comprising:
- naproxen dissolved or dispersed in at least one carrier, and
- an alkali agent sufficient to partially neutralize a portion of said naproxen by forming an equilibrium between (1) said naproxen and (2) the salt of said naproxen and said alkali agent,
- wherein the fill has a pH greater than 7.5, and
- wherein the shell exhibits resistance to degradation caused by alkaline fills.
A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:
- a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1;
- and
- a fill, said fill comprising:
- at least one active ingredient dissolved or dispersed in at least one carrier,
- wherein the fill has a pH greater than 7.5, and
- wherein the shell exhibits resistance to degradation caused by alkaline fills,
- wherein said at least one active ingredient is selected from the group consisting of pseudoephedrine hydrochloride, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, diphenhydramine, aspirin, caffeine, ranitidine, cimetidine, celecoxib, ritonavir, fexofenadine, and combinations thereof.
Dependencies are inferred from the claim text.